U.S. President Donald Trump’s announcement that all 50 states will join his proposed drug-price lowering policy is leading Canadian pharmaceutical experts and international researchers to warn how prices could rise around the world.
On Sept. 18, Trump announced in the Oval Office that all state Medicaid programs for Americans with low incomes will benefit from lower prescription drug prices under agreements with pharmaceutical manufacturers to match the lowest prices paid by other developed nations.
“We went from paying the highest drug prices in the world to paying the lowest drug prices in the world,” Trump said about the intention of the new policy.
